Acasti Pharma Stock Price

0.04 (3.33%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 257,917
Bid Price 1.20
Ask Price 1.28
News -
Day High 1.29


52 Week Range


Day Low 1.17
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Acasti Pharma Inc ACST NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 3.33% 1.24 18:42:36
Open Price Low Price High Price Close Price Prev Close
1.24 1.17 1.29 1.23 1.20
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,408 257,917 $ 1.24 $ 319,287 - 0.244 - 2.9392
Last Trade Time Type Quantity Stock Price Currency
17:10:02 8 $ 1.24 USD


Draw Mode:

Acasti Pharma Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 54.92M 44.29M 44.26M $ 196.00k $ - -1.32 -2.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.44M 5.40%

more financials information »

Acasti Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ACST Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.371.371.101.24492,671-0.13-9.49%
1 Month1.721.731.101.40379,726-0.48-27.91%
3 Months2.202.381.101.79457,803-0.96-43.64%
6 Months0.57922.93920.3850.63752984,640,2930.6608114.09%
1 Year0.30492.93920.2440.632585318,473,7300.9351306.69%
3 Years0.673.080.1710.68610238,027,3400.5785.07%
5 Years1.373.35650.1710.70588074,992,805-0.13-9.49%

Acasti Pharma Description

Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all which could help to increase treatment compliance and improve patient outcomes.

Your Recent History
Acasti Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.